Vancouver, B.C. - TheNewswire - July 30, 2020 – SOLARVEST BIOENERGY INC. (TSXV:SVS) (“Solarvest” or the “Company”) today announced that its Chief Financial Officer Joseph Heng has resigned from the Company. The effective date of his resignation was July 23, 2020. The Company wishes Mr. Heng all the best in his retirement and wishes to thank him for all the years of service, financial support and sage advice.  

The Company will commence an executive search for a new Chief Financial Officer.

About Solarvest:

Solarvest BioEnergy Inc. is an algae biotechnology company whose production platform provides it with an extremely flexible system capable of producing numerous products from Omega 3 fatty acids to human therapeutic proteins. The company has successfully demonstrated (news release dated March 16th. 2015) the expression of BMP, a high value therapeutic protein, recombinant viral antigens (immune stimulating proteins), and Cecropins (antimicrobial peptide/protein). The company has initiated a program for the expression of CBD and THC proteins to be produced in GMP fermentation facilities.  

For further information contact:         

Gerri Greenham, Chief Executive Officer

Tel: 416 420 0947 Email: ggreenham@solarvest.ca

The TSX Venture Exchange has neither approved nor disapproved the contents of this news release.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Statements made in this news release may contain forward-looking statements that may involve a number of risks and uncertainties.  Actual events or results could differ materially from the Company’s expectations and projections.